JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $152 to $170.
JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $152 to $170.